Skip to main content
Clinical Trials/CTRI/2024/01/061163
CTRI/2024/01/061163CompletedPhase 4

A Clinical Study to evaluate the 8-hour moisturization potential of Multiple Saliguard Samples at concentration 3%. - NI

Salicylates & Chemicals Pvt. Ltd.0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1) Gender: Male or Female with age 18-40
  • 2) Subjects willing to give written informed consent
  • 3) Women of child bearing potential must have a negative urine
  • pregnancy test prior to study entry.
  • 4) Are free of any systemic or dermatologic disorder, which, in
  • the opinion of the investigator, will interfere with the study
  • results or increase the risk of adverse events.
  • 5) Are willing to avoid prolonged exposure of the treatment area
  • to ultraviolet radiation (natural or artificial) for the duration of

Exclusion Criteria

  • 1. Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study.
  • 2. Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition.
  • 3. Have open sores or open lesions in the treatment area(s).
  • 4. Have any condition that, in the opinion of the investigator, would confound the safety and efficacy assessments of the
  • 5. Have participated in any interventional clinical trial in the previous 90 days.
  • 6. Have a known sensitivity to any of the constituents of the test product.
  • 7. Have used, are using, or are planning to use
  • immunosuppressive or immunomodulatory medication (i.e.,biologics), including corticosteroids.
  • 8. Have not skin related issues

Investigators

Sponsor
Salicylates & Chemicals Pvt. Ltd.

Similar Trials

To test the moisturization of products. | Clinical Trial